Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Neon Therapeutics Inc (NTGN)

Neon Therapeutics Inc (NTGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 88,929
  • Shares Outstanding, K 28,967
  • Annual Sales, $ 0 K
  • Annual Income, $ -79,780 K
  • 60-Month Beta -0.81
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.15
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.10
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/11/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.27
  • Number of Estimates 1
  • High Estimate -0.27
  • Low Estimate -0.27
  • Prior Year -0.79
  • Growth Rate Est. (year over year) +65.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.11 +45.50%
on 04/16/20
3.35 -8.36%
on 04/23/20
+0.54 (+21.34%)
since 04/03/20
3-Month
1.37 +124.09%
on 03/12/20
3.35 -8.36%
on 04/23/20
+1.60 (+108.84%)
since 02/05/20
52-Week
0.88 +248.86%
on 12/05/19
6.25 -50.88%
on 05/06/19
-3.06 (-49.92%)
since 05/03/19

Most Recent Stories

More News
Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results

--- Infinity Voluntarily Pausing Enrollment on MARIO-275 to Evaluate the Risk/Benefit for Patients -

INFI : 1.1000 (+0.92%)
NTGN : 3.07 (+8.10%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (NASDAQ:NTGN),(NASDAQ:SBBX),(NASDAQ:QUMU),(NasdaqGM:MSBF), EQNX::TICKER_END

NTGN : 3.07 (+8.10%)
SBBX : 18.51 (-4.29%)
QUMU : 5.33 (-5.66%)
MSBF : 10.38 (+1.86%)
Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01

Neon Therapeutics, Inc. (Nasdaq: NTGN) today announced the acceptance of its Clinical Trial Authorization (CTA) from the Dutch Health Authority (DHA) for its personal neoantigen-targeted T cell therapy...

NTGN : 3.07 (+8.10%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.

Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Neon Therapeutics, Inc. ("Neon" or the...

NTGN : 3.07 (+8.10%)
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Neon Therapeutics, Inc. (NTGN)

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York, Case No. 1:20-cv-03033 on behalf of shareholders...

NTGN : 3.07 (+8.10%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (NASDAQ:NTGN),(NASDAQ:SBBX),(NASDAQ:QUMU),(NasdaqGM:MSBF), EQNX::TICKER_END

NTGN : 3.07 (+8.10%)
SBBX : 18.51 (-4.29%)
QUMU : 5.33 (-5.66%)
MSBF : 10.38 (+1.86%)
NTGN, ETFC, TTPH, and MINI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

ETFC : 51.95 (-0.17%)
MINI : 29.50 (-6.47%)
NTGN : 3.07 (+8.10%)
TTPH : 2.20 (-3.51%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (NASDAQ:NTGN),(NASDAQ:MSBF),(NASDAQ:QUMU),(NASDAQ:SBBX), EQNX::TICKER_END

NTGN : 3.07 (+8.10%)
MSBF : 10.38 (+1.86%)
QUMU : 5.33 (-5.66%)
SBBX : 18.51 (-4.29%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Neon Therapeutics, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Neon Therapeutics, Inc. ("NTGN" or the "Company") (NASDAQ: NTGN) in connection...

NTGN : 3.07 (+8.10%)
BNTX : 67.00 (+0.33%)
FG, POPE, OPB, and NTGN SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

NTGN : 3.07 (+8.10%)
OPB : 19.49 (-2.35%)
POPE : 98.00 (+0.37%)
FG : 8.39 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade NTGN with:

Business Summary

Neon Therapeutics Inc. is a clinical-stage immuno-oncology company. It engaged in developing neoantigen-based therapeutics for the treatment of cancer by directing the immune system. The company's product pipeline consists of NEO-PV-01, NEO-PTC-01 and NEO-SV-01 which are in clinical stage. Neon Therapeutics...

See More

Key Turning Points

2nd Resistance Point 3.20
1st Resistance Point 3.13
Last Price 3.07
1st Support Level 2.96
2nd Support Level 2.85

See More

52-Week High 6.25
Fibonacci 61.8% 4.20
Fibonacci 50% 3.57
Last Price 3.07
Fibonacci 38.2% 2.93
52-Week Low 0.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar